Showing results (131-140 of 394) with videos related to
Sort By:
Pageof 40
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2010
Lesion enhancement diminishes with time in primary progressive multiple sclerosisZ Khaleeli, O Ciccarelli, K Mizskiel, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1985
Suspected and clinically definite multiple sclerosis: the relationship between CSF immunoglobulins and clinical courseA J Thompson, M Hutchinson, E A Martin, et al.The Journal of Pharmacy and Pharmacology|November 1, 1986
The pharmacokinetics of pyrimethamine in the rat: effect of mefloquineM D Coleman, A J Thompson, G Edwards, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
EDMUS, a European database for multiple sclerosisC Confavreux, D A Compston, O R Hommes, et al.The British Journal of Radiology|July 8, 2000
The incidence and significance of testicular microlithiasis in a subfertile populationK Thomas, S J Wood, A J Thompson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 20, 2010
Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosisK Rejdak, S M Leary, A Petzold, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1996
Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosisN A Losseff, D P Kingsley, W I McDonald, et al.Brain : a Journal of Neurology|June 10, 1998
An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosisG L Sheean, N M Murray, J C Rothwell, et al.The American Journal of Pathology|December 1, 1980
Kappa light chain glomerulosclerosis in multiple myelomaA E Seymour, A J Thompson, P S Smith, et al.Brain : a Journal of Neurology|August 1, 1993
Brain MRI changes in phenylketonuria. Associations with dietary statusA J Thompson, S Tillotson, I Smith, et al.Pageof 40